Macrolides in the treatment of asthma

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 1, 2012, Pages 76-84

  Good Jr , James T ^a   Rollins, Donald R ^a   Martin, Richard J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

asthma; Chlamydophila pneumoniae; fiberoptic bronchoscopy; macrolides; Mycoplasma pneumoniae

Indexed keywords

ALPHA INTERFERON; AZITHROMYCIN; BETA INTERFERON; CORTICOSTEROID; ERYTHROMYCIN; GAMMA INTERFERON; INTERLEUKIN 4; MACROLIDE; PLACEBO; TELITHROMYCIN;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ASTHMA; BACTERIAL INFECTION; BRONCHOSCOPY; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; INNATE IMMUNITY; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUORUM SENSING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ASTHMA; BRONCHOSCOPY; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; LUNG; MACROLIDES; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION;

EID: 83155173916     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32834daff8     Document Type: Review

References (53)

1. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181:315-323.
2. Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010; 376:826-834.
3. Dulek DE, Peebles RS Jr. Viruses and asthma. Biochim Biophys Acta 2011; 1810:1080-1090.
4. Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 2010; 125:1178-1187; quiz 1188-1179.
5. Kloepfer KM, Gern JE. Virus/allergen interactions and exacerbations of asthma. Immunol Allergy Clin North Am 2010; 30:553-563, vii.
6. Lee SL, Chiu SS, Malik PJ, et al. Is respiratory viral infection really an important trigger of asthma exacerbations in children? Eur J Pediatr 2011; 170:1317-1324.
7. Papadopoulos NG, Christodoulou I, Rohde G, et al. Viruses and bacteria in acute asthma exacerbations: a GA(2) LEN-DARE systematic review. Allergy 2011; 66:458-468.
8. Rosenthal LA, Avila PC, Heymann PW, et al. Viral respiratory tract infections and asthma: the course ahead. J Allergy Clin Immunol 2010; 125:1212-1217.
9. Huang YJ, Nelson CE, Brodie EL, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011; 127:372-381; e371-e373.
10. Specjalski K, Jassem E. Chlamydophila pneumoniae, Mycoplasma pneumoniae infections, and asthma control. Allergy Asthma Proc 2011; 32:9-17.
11. Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest 2007; 132:1962-1966.
12. Good J, Kolakowski C, Groshong S, et al. Refractory asthma: importance of bronchoscopy to identify phenotypes and direct therapy. Chest 2011; doi: .10.1378/chest.11-0741 [Epub ahead of print].
13. Kraft M, Cassell GH, Pak J, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002; 121:1782-1788. (Pubitemid 34634396)
14. Vanaudenaerde BM, Vos R, Meyts I, et al. Macrolide therapy targets a specific phenotype in respiratory medicine: from clinical experience to basic science and back. Inflamm Allergy Drug Targets 2008; 7:279-287.
15. Ege MJ, Mayer M, Normand AC, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011; 364:701-709.
16. Chu HW, Honour JM, Rawlinson CA, et al. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003; 71:1520-1526. (Pubitemid 36254340)
17. Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. I: Epidemiology. Clin Exp Allergy 1992; 22:325-336.
18. Holgate ST. The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev 2011; 242:205-219.
19. Matsumoto M, Oshiumi H, Seya T. Antiviral responses induced by the TLR3 pathway. Rev Med Virol 2011; 21:67-77.
20. Fraenkel DJ, Bardin PG, Sanderson G, et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995; 151:879-886.
21. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201:937-947. (Pubitemid 40524463)
22. Wark PA, Grissell T, Davies B, et al. Diversity in the bronchial epithelial cell response to infection with different rhinovirus strains. Respirology 2009; 14:180-186.
23. Cakebread JA, Xu Y, Grainge C, et al. Exogenous IFN-beta has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. J Allergy Clin Immunol 2011; 127:1148-1154; e1149.
24. Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487-1495. (Pubitemid 47572634)
25. Andersen P. Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. Thorax 1998; 53:302-307. (Pubitemid 28215793)
26. Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol 2008; 3:635-648.
27. Metz G, Kraft M. Effects of atypical infections with Mycoplasma and Chlamydia on asthma. Immunol Allergy Clin North Am 2010; 30:575-585; vii-viii.
28. Blasi F, Tarsia P, Aliberti S. Chlamydophila pneumoniae. Clin Microbiol Infect 2009; 15:29-35.
29. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997; 278:901-904. (Pubitemid 27492241)
30. Daniels JM, Snijders D, de Graaff CS, et al. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181:150-157.
31. Graham VA, Milton AF, Knowles GK, et al. Routine antibiotics in hospital management of acute asthma. Lancet 1982; 1:418-420.
32. Shapiro GG, Eggleston PA, Pierson WE, et al. Double-blind study of the effectiveness of a broad spectrum antibiotic in status asthmaticus. Pediatrics 1974; 53:867-872.
33. Johnston SL, Blasi F, Black PN, et al. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006; 354:1589-1600.
34. Martin RJ, Kraft M, Chu HW, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107:595-601. (Pubitemid 32397743)
35. Sutherland ER, King TS, Icitovic N, et al. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 2010; 126:747-753.
36. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One 2010; 5:e8578.
37. Jain R, Danziger LH. The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. Curr Pharm Des 2004; 10:3045-3053. (Pubitemid 39242900)
38. Friedlander AL, Albert RK. Chronic macrolide therapy in inflammatory airways diseases. Chest 2010; 138:1202-1212.
39. Jaffé A, Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol 2001; 31:464-473. (Pubitemid 32523640)
40. Kudoh S, Azuma A, Yamamoto M, et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998; 157:1829-1832.
41. Kudoh S, Uetake T, Hagiwara K, et al. Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Nihon Kyobu Shikkan Gakkai Zasshi 1987; 25:632-642. (Pubitemid 17141772)
42. Altenburg J, de Graaff CS, van der Werf TS, et al. Immunomodulatory effects of macrolide antibiotics. Part 1: Biological mechanisms. Respiration 2011; 81:67-74.
43. Kondoh K, Hashiba M, Baba S. Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa. Acta Otolaryngol Suppl 1996; 525:56-60. (Pubitemid 26332363)
44. Ichimiya T, Yamasaki T, Nasu M. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother 1994; 34:331-341. (Pubitemid 24311589)
45. Nalca Y, Jansch L, Bredenbruch F, et al. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 2006; 50:1680-1688.
46. Tsang KW, Ng P, Ho PL, et al. Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro. Eur Respir J 2003; 21:401-406. (Pubitemid 36336196)
47. Kawamura-Sato K, Iinuma Y, Hasegawa T, et al. Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis. Antimicrob Agents Chemother 2000; 44:2869-2872.
48. Kita E, Sawaki M, Oku D, et al. Suppression of virulence factors of Pseudomonas aeruginosa by erythromycin. J Antimicrob Chemother 1991; 27:273-284.
49. Culic O, Erakovic V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001; 429:209-229. (Pubitemid 33043997)
50. Xu G, Fujita J, Negayama K, et al. Effect of macrolide antibiotics on macrophage functions. Microbiol Immunol 1996; 40:473-479. (Pubitemid 126481262)
51. Mukae H, Kadota J, Kohno S, et al. Increase in activated CD8\+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med 1995; 152:613-618.
52. Kadota J, Mizunoe S, Kishi K, et al. Antibiotic-induced apoptosis in human activated peripheral lymphocytes. Int J Antimicrob Agents 2005; 25:216-220. (Pubitemid 40292751)
53. WilliamsAC,Galley HF,Watt AM, et al. Differential effects of three antibiotics on Thelper cell cytokine expression. J Antimicrob Chemother 2005; 56:502-506.